As of 2025-07-07, the EV/EBITDA ratio of AMP Alternative Medical Products Inc (XCX.CN) is -27.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XCX.CN's latest enterprise value is 3.18 mil CAD. XCX.CN's TTM EBITDA according to its financial statements is -0.12 mil CAD. Dividing these 2 quantities gives us the above XCX.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-07-02 | -27.31 |
| 2025-06-30 | -31.75 |
| 2025-06-13 | -31.75 |
| 2025-06-12 | -31.75 |
| 2025-06-05 | -27.31 |
| 2025-05-29 | -27.31 |
| 2025-05-28 | -27.31 |
| 2025-05-27 | -36.19 |
| 2025-05-26 | -27.31 |
| 2025-05-09 | -27.31 |
| 2025-04-28 | -31.75 |
| 2025-04-23 | -31.75 |
| 2025-04-07 | -31.75 |